Financial results - RADIATION ONCOLOGY RESEARCH TEAM S.R.L.

Financial Summary - Radiation Oncology Research Team S.r.l.
Unique identification code: 42831030
Registration number: J16/1268/2020
Nace: 7211
Sales - Ron
27.996
Net Profit - Ron
24.264
Employee
1
The most important financial indicators for the company Radiation Oncology Research Team S.r.l. - Unique Identification Number 42831030: sales in 2023 was 27.996 euro, registering a net profit of 24.264 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in biotehnologie having the NACE code 7211.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Radiation Oncology Research Team S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - - 4.962 11.118 28.683 27.996
Total Income - EUR - - - - - - 4.962 11.118 28.706 33.432
Total Expenses - EUR - - - - - - 28 51 839 8.888
Gross Profit/Loss - EUR - - - - - - 4.934 11.068 27.867 24.544
Net Profit/Loss - EUR - - - - - - 4.795 10.734 27.186 24.264
Employees - - - - - - 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -2.1%, from 28.683 euro in the year 2022, to 27.996 euro in 2023. The Net Profit decreased by -2.839 euro, from 27.186 euro in 2022, to 24.264 in the last year.

Check the financial reports for the company - Radiation Oncology Research Team S.r.l.

Rating financiar

Financial Rating -
Radiation Oncology Research Team...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Radiation Oncology Research Team...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Radiation Oncology Research Team...

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Radiation Oncology Research Team...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Radiation Oncology Research Team S.r.l. - CUI 42831030

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - - - 0 0 0 0
Current Assets - - - - - - 4.983 10.874 30.795 27.474
Inventories - - - - - - 0 0 0 0
Receivables - - - - - - 3.101 0 20.706 19.435
Cash - - - - - - 1.882 10.874 10.088 8.039
Shareholders Funds - - - - - - 4.837 10.783 27.235 24.313
Social Capital - - - - - - 41 40 41 40
Debts - - - - - - 147 91 3.560 3.162
Income in Advance - - - - - - 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7211 - 7211"
CAEN Financial Year 7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 27.474 euro in 2023 which includes Inventories of 0 euro, Receivables of 19.435 euro and cash availability of 8.039 euro.
The company's Equity was valued at 24.313 euro, while total Liabilities amounted to 3.162 euro. Equity decreased by -2.839 euro, from 27.235 euro in 2022, to 24.313 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Radiation Oncology Research Team S.r.l.

Comments - Radiation Oncology Research Team S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.